| NCT06523153 | A Study of the Investigational Monoclonal Antibody, VYD2311, in Healthy Participants | ACTIVE_NOT_RECRUITING | PHASE1 | 2024-08-28 | 2025-05 | 2025-05 |
| NCT06039449 | A Study to Investigate the Prevention of COVID-19 WithVYD222 in Adults with Immune Compromise and in Participants Aged 12 Years or Older Who Are At Risk of Exposure to SARS-CoV-2 | COMPLETED | PHASE3 | 2023-09-08 | 2024-11-19 | 2024-11-19 |
| NCT05791318 | A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of the Monoclonal Antibody VYD222 in Healthy Adult Participants | COMPLETED | PHASE1 | 2023-03-28 | 2024-05-08 | 2024-05-08 |
| NCT04805671 | Evaluation of ADG20 for the Treatment of Mild or Moderate COVID-19 | TERMINATED | PHASE2, PHASE3 | 2021-07-26 | 2022-11-03 | 2022-02-10 |
| NCT04859517 | Evaluation of ADG20 for the Prevention of COVID-19 | TERMINATED | PHASE2, PHASE3 | 2021-04-27 | 2022-11-04 | 2022-11-04 |